Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-606001 as an Add-on to ERT in Late-onset Pompe Disease
NCT07123155Phase 2Recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Oct 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of S-606001 in Pompe disease, sponsored by Shionogi & Co., Ltd.. Started Oct 2025; status: recruiting.
02
Drugs
S-606001
03
Conditions
Pompe disease
Beyond the preview
Go deeper on NCT07123155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07123155.